Practice Management

Top Story

Victoza will not be expanded for type 1 diabetes use

August 30, 2015

Novo Nordisk does not intend to submit an application to expand the label of Victoza for use in type 1 diabetes, following phase 3a trial results that showed a significantly higher rate of hypoglycemia in adults assigned the drug compared with those assigned a placebo.

"The results of the two ADJUNCT trials show that liraglutide as adjunct to insulin therapy met the primary endpoint of improving blood glucose control for people with type 1 diabetes, however, unfortunately without the hypoglycemic benefit experienced in type 2 diabetes,” Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk, said in a statement. "We are disappointed, as we believed in the potential to provide people with type 1 diabetes with a new treatment option, and we will continue to invest in new treatment options for this group of people."

FDA News

FDA: DPP-IV inhibitors may cause severe joint pain

August 28, 2015
The FDA recently a warned that the medications Januvia, Onglyza, Tradjenta and Nesina may cause joint pain that is severe and disabling, according to a press release. It…
In the Journals

Growth hormone reduces osteoporotic fracture risk in older women

August 28, 2015
Older women with osteoporosis treated with growth hormone showed a reduced risk for fracture and improved bone density that continued for years after stopping treatment…
FDA News

FDA approves Synjardy for type 2 diabetes

August 28, 2015
The FDA has approved Synjardy to control blood glucose levels in adults with type 2 diabetes, according to a release from Boehringer Ingelheim Pharmaceuticals and Eli…
CME
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

This activity is supported by educational grants from Eisai, Inc. and Vivus, Inc.

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: Joint position statement addresses diabetes self-management education

VIDEO: Joint position statement addresses diabetes self-management education

June 12, 2015
BOSTON — Linda M. Siminerio, RN, PhD, CDE, of the University of Pittsburgh, discusses a newly released joint…
More »

Victoza will not be expanded for type 1 diabetes use

August 30, 2015
Novo Nordisk does not intend to submit an application to expand the label of Victoza for use in type 1 diabetes, following phase 3a trial results…
FDA News

FDA: DPP-IV inhibitors may cause severe joint pain

August 28, 2015
The FDA recently a warned that the medications Januvia, Onglyza, Tradjenta and Nesina may cause joint pain that is severe and disabling, according to…
In the Journals

Growth hormone reduces osteoporotic fracture risk in older women

August 28, 2015
Older women with osteoporosis treated with growth hormone showed a reduced risk for fracture and improved bone density that continued for years after…
FDA News

FDA approves Synjardy for type 2 diabetes

August 28, 2015
The FDA has approved Synjardy to control blood glucose levels in adults with type 2 diabetes, according to a release from Boehringer Ingelheim…
FDA News

FDA: Lots of OmniPod insulin management system recalled

August 28, 2015
In early July, Insulet Corporation initiated a voluntary recall of 40,846 boxes of the OmniPod Insulin Management System, according to an FDA press…
In the Journals

Brief interruption of sedentary behavior improves blood glucose in children

August 27, 2015
Children’s blood glucose levels could be improved by simply taking short breaks to walk during sedentary activities, according to recent study…
FDA News

FDA issues draft guidance on nonproprietary naming of biologics, biosimilars

August 27, 2015
The FDA today announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products.According to…
In the Journals

Overall global health improving, years lived with disability rising

August 27, 2015
Around the world, the average life expectancy increased by more than 6 years between 1990 and 2013; however, individuals are spending more years than…
In the Journals

Type 2 diabetes diagnosis related to antibiotic use

August 27, 2015
More antibiotic use was found among people with type 2 diabetes in the years leading up to the diagnosis compared with people without type 2…
Jan Westerink In the Journals

HbA1c levels CV events modestly related in type 2 diabetes

August 26, 2015
A modest, but not statistically significant, relationship was found between HbA1c levels and cardiovascular events in people with type 2 diabetes…
More Headlines »
morganatic-roan